<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1870-7203</journal-id>
<journal-title><![CDATA[Acta médica Grupo Ángeles]]></journal-title>
<abbrev-journal-title><![CDATA[Acta méd. Grupo Ángeles]]></abbrev-journal-title>
<issn>1870-7203</issn>
<publisher>
<publisher-name><![CDATA[Grupo Ángeles, Servicios de Salud]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1870-72032020000100067</article-id>
<article-id pub-id-type="doi">10.35366/92003</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Ultrasonido contrastado con microburbujas para el diagnóstico no invasivo de hepatocarcinoma]]></article-title>
<article-title xml:lang="en"><![CDATA[Microbubble-contrast ultrasound for the non-invasive diagnosis of hepatocarcinoma]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ramírez Gutiérrez de Velasco]]></surname>
<given-names><![CDATA[Alfredo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vega López]]></surname>
<given-names><![CDATA[César A]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pérez González]]></surname>
<given-names><![CDATA[Adrián F]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Paredes Manjarrez]]></surname>
<given-names><![CDATA[Carlos]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Quiroz Castro]]></surname>
<given-names><![CDATA[Óscar]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Ángeles Pedregal  ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Ángeles Pedregal  ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Hospital Ángeles Pedregal Departamento de Imagenología ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Hospital Ángeles Pedregal Departamento de Imagenología ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2020</year>
</pub-date>
<volume>18</volume>
<numero>1</numero>
<fpage>67</fpage>
<lpage>70</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S1870-72032020000100067&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S1870-72032020000100067&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S1870-72032020000100067&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen: El ultrasonido con medio de contraste (USMC) se aprobó en 2016 para lesiones hepáticas y, desde entonces, ha sido el método diagnóstico para el hepatocarcinoma, cuya sensibilidad y especificidad es muy parecida a la tomografía computarizada y a la resonancia magnética. Las microburbujas se administran por vía intravenosa y tienen una eliminación pulmonar, lo que hace que se pueda utilizar en pacientes nefrópatas. Con el USMC, se pueden valorar en tiempo real las distintas fases de la circulación hepática, por lo que el hepatocarcinoma tiene características específicas que, según el LI-RADS (Liver Imaging Reporting and Data System), se puede tener una certeza bastante elevada de su diagnóstico. Se concluye que el USMC tiene ventajas y desventajas para el diagnóstico y seguimiento de pacientes con hepatocarcinoma, por lo que se deberán de tomar en cuenta al momento de estudiar a estos pacientes y considerarla como una herramienta eficaz para el mismo.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract: Contrast-Enhanced Ultrasound (CEUS) was approved in 2016 for its use in hepatic lesions. Ever since its approval, it has been used for the diagnosis of Hepatocellular Carcinoma (HCC) with a similar sensitivity and specificity than Computed Tomography and Magnetic Resonance. The microbubles are administered intravenously and have pulmonary elimination, which makes them an ideal study for patients with chronic kidney disease. CEUS allows us to evaluate hepatic lesions in real time with their different contrast phases, and recognize the specific features of HCC that according to the LI-RADS classification (Liver Imaging Reporting and Data System), it can be diagnosed with high accuracy. CEUS has many advantages and disadvantages for the diagnosis and follow up of HCC, they should all be taken into consideration during the evaluation of these patients and consider CEUS as a valuable diagnostic tool.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Hepatocarcinoma]]></kwd>
<kwd lng="es"><![CDATA[ultrasonido contrastado]]></kwd>
<kwd lng="es"><![CDATA[microburbujas]]></kwd>
<kwd lng="es"><![CDATA[LI-RADS]]></kwd>
<kwd lng="en"><![CDATA[Hepatocarcinoma]]></kwd>
<kwd lng="en"><![CDATA[contrast ultrasound]]></kwd>
<kwd lng="en"><![CDATA[microbubbles]]></kwd>
<kwd lng="en"><![CDATA[LI-RADS]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ferraioli]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Meloni]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Contrast-enhanced ultrasonography of the liver using SonoVue]]></article-title>
<source><![CDATA[Ultrasonography]]></source>
<year>2018</year>
<volume>37</volume>
<page-range>25-35</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Konopke]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Kersting]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Bergert]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Contrast-enhanced ultrasonography to detect liver metastases : a prospective trial to compare transcutaneous unenhanced and contrast-enhanced ultrasonography in patients undergoing laparotomy]]></article-title>
<source><![CDATA[Int J Colorectal Dis]]></source>
<year>2007</year>
<volume>22</volume>
<page-range>201</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dietrich]]></surname>
<given-names><![CDATA[CF]]></given-names>
</name>
<name>
<surname><![CDATA[Averkiou]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Nielsen]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
<name>
<surname><![CDATA[Barr]]></surname>
<given-names><![CDATA[RG]]></given-names>
</name>
<name>
<surname><![CDATA[Burns]]></surname>
<given-names><![CDATA[PN]]></given-names>
</name>
<name>
<surname><![CDATA[Calliada]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[How to perform contrasted-enhanced ultrasound (CEUS)]]></article-title>
<source><![CDATA[Ultasound Int Open]]></source>
<year>2017</year>
<page-range>E2-E15</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Piscaglia]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Bolondi]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The safety of Sonovue in abdominal applications: retrospective analysis of 23,188 investigations]]></article-title>
<collab>Italian Society for Ultrasound in Medicine and Biology (SIUMB), Study Group on Ultra-sound Contrast Agents</collab>
<source><![CDATA[Ultrasound Med Bio]]></source>
<year>2006</year>
<volume>32</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1369-75</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wei]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Mulvagh]]></surname>
<given-names><![CDATA[SL]]></given-names>
</name>
<name>
<surname><![CDATA[Carson]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Davidoff]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Gabriel]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Grimm]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The safety of DeFinity and Optison for ultrasound image enhancement: a retrospective analysis of 78,383 administered contrast doses]]></article-title>
<source><![CDATA[J Am Soc Echocardiogr]]></source>
<year>2008</year>
<volume>21</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1202-6</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Claudon]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Dietrich]]></surname>
<given-names><![CDATA[CF]]></given-names>
</name>
<name>
<surname><![CDATA[Choi]]></surname>
<given-names><![CDATA[BI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver -update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS]]></article-title>
<source><![CDATA[Ultrasound Med Biol]]></source>
<year>2013</year>
<volume>39</volume>
<page-range>187</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Jang]]></surname>
<given-names><![CDATA[HJ]]></given-names>
</name>
<name>
<surname><![CDATA[Khalili]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[TK]]></given-names>
</name>
<name>
<surname><![CDATA[Atri]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Successful integration of contrast enhanced us into routine abdominal imaging]]></article-title>
<source><![CDATA[Radiographics]]></source>
<year>2018</year>
<volume>38</volume>
<page-range>1454-77</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<collab>American College of Radiology</collab>
<source><![CDATA[ACR CEUS LI-RADS 2017 [Internet]]]></source>
<year>2018</year>
<publisher-name><![CDATA[American College of Radiology]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Seitz]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Bernatik]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Strobel]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Blank]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Friedrich-Rust]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Strunk]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Greis]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs MRI--a prospective comparison in 269 patients]]></article-title>
<source><![CDATA[Ultraschall Med]]></source>
<year>2010</year>
<volume>31</volume>
<page-range>492</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[lsayes]]></surname>
<given-names><![CDATA[KM]]></given-names>
</name>
<name>
<surname><![CDATA[Kielar]]></surname>
<given-names><![CDATA[AZ]]></given-names>
</name>
<name>
<surname><![CDATA[Chernyak]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Morshid]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[F an]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Marks]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance]]></article-title>
<source><![CDATA[J Hepatocell Carcinoma]]></source>
<year>2019</year>
<volume>6</volume>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
